SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-009713
Filing Date
2023-04-07
Accepted
2023-04-06 19:58:56
Documents
13
Period of Report
2023-04-06
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20230406_8k.htm   iXBRL 8-K 26716
  Complete submission text file 0001437749-23-009713.txt   159660

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wint-20230406.xsd EX-101.SCH 3601
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20230406_def.xml EX-101.DEF 11532
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20230406_lab.xml EX-101.LAB 15414
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20230406_pre.xml EX-101.PRE 11688
7 EXTRACTED XBRL INSTANCE DOCUMENT wint20230406_8k_htm.xml XML 2582
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 23807511
SIC: 2836 Biological Products, (No Diagnostic Substances)